Unknown

Dataset Information

0

Prognostic impact of HbA1c variability on long-term outcomes in patients with heart failure and type 2 diabetes mellitus.


ABSTRACT:

Background

The prognostic impact of long-term glycemic variability on clinical outcomes in patients with heart failure (HF) and type 2 diabetes mellitus (T2DM) remains unclear. We determined and compared hemoglobin A1c (HbA1c) variability and clinical outcomes for patients with HF with preserved ejection fraction (HFpEF), HF with mid-range ejection fraction (HFmrEF) and HF with reduced ejection fraction (HFrEF) in a prospective longitudinal study.

Methods

Patients with HF and T2DM, undergone 3 or more HbA1c determinations during the first 18 months, were then followed for 42 months. The primary outcome was death from any cause. Secondary outcome was composite endpoints with death and HF hospitalization. Cox proportional hazards models were used to compare outcomes for patients with HFpEF, HFmrEF and HFrEF.

Results

Of 902 patients enrolled, 32.2% had HFpEF, 14.5% HFmrEF, and 53.3% HFrEF. During 42 months of follow-up, 270 (29.9%) patients died and 545 (60.4%) patients experienced composite endpoints of death and HF readmission. The risk of all-cause death or composite endpoints was lower for HFpEF than HFrEF. Moreover, higher HbA1c variability was associated with higher all-cause mortality or composite endpoints and HbA1c variability was an independent predictor of all-cause mortality or composite endpoints, regardless of EF.

Conclusions

This prospective longitudinal study showed that the all-cause death and composite events was lower for HFpEF than HFrEF. HbA1c variability was independently and similarly predictive of death or combined endpoints in the three HF phenotypes.

SUBMITTER: Gu J 

PROVIDER: S-EPMC6026342 | biostudies-literature | 2018 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Prognostic impact of HbA1c variability on long-term outcomes in patients with heart failure and type 2 diabetes mellitus.

Gu Jun J   Pan Jian-An JA   Fan Yu-Qi YQ   Zhang Hui-Li HL   Zhang Jun-Feng JF   Wang Chang-Qian CQ   Wang Chang-Qian CQ  

Cardiovascular diabetology 20180630 1


<h4>Background</h4>The prognostic impact of long-term glycemic variability on clinical outcomes in patients with heart failure (HF) and type 2 diabetes mellitus (T2DM) remains unclear. We determined and compared hemoglobin A1c (HbA1c) variability and clinical outcomes for patients with HF with preserved ejection fraction (HFpEF), HF with mid-range ejection fraction (HFmrEF) and HF with reduced ejection fraction (HFrEF) in a prospective longitudinal study.<h4>Methods</h4>Patients with HF and T2DM  ...[more]

Similar Datasets

| S-EPMC10148792 | biostudies-literature
| S-EPMC4366571 | biostudies-literature
| S-EPMC9402888 | biostudies-literature
| S-EPMC6159396 | biostudies-other
| S-EPMC7664459 | biostudies-literature
| S-EPMC8037774 | biostudies-literature
| S-EPMC6881005 | biostudies-literature
| S-EPMC8318432 | biostudies-literature
| S-EPMC5494155 | biostudies-other
| S-EPMC8177638 | biostudies-literature